Lee Jun Hee, Gu Byung Mo, Song Hyeong Hun, Jang You Jin, Kim Hyun Koo
Department of Thoracic and Cardiovascular Surgery, Guro Hospital, Korea University College of Medicine, Seoul 08308, Republic of Korea.
Department of Medicine, Korea University College of Medicine, Seoul 02841, Republic of Korea.
Cancers (Basel). 2025 Mar 21;17(7):1052. doi: 10.3390/cancers17071052.
Robot-assisted minimally invasive esophagectomy (RAMIE) has gained global popularity. Recent randomized controlled trials have demonstrated that RAMIE results in reduced operative times and a greater number of dissected lymph nodes compared to conventional minimally invasive esophagectomy (MIE). This study provides an initial analysis of single-port (SP) robot-assisted minimally invasive esophagectomy (SRAMIE) using the SP robotic system via the subcostal approach. The primary objective is to examine perioperative outcomes of SRAMIE compared to multi-port RAMIE (MRAMIE) using the Xi robotic system and video-assisted thoracoscopic esophagectomy (VAE).
In this retrospective study, patients who underwent MIE at a single center between February 2017 and December 2024 were analyzed. Patients were divided into SRAMIE ( = 17), MRAMIE ( = 13), and VAE ( = 23) groups. The primary outcome was the incidence of postoperative complications. Secondary outcomes included chest tube duration, length of postoperative hospital stay, postoperative pain levels, and 30-day mortality.
The SRAMIE group did not experience conversions to thoracotomy or VAE. Compared with VAE, SRAMIE resulted in significantly shorter chest tube duration ( = 0.038), shorter postoperative hospital stays ( = 0.036), and lower peak postoperative pain ( = 0.003). No significant differences were observed among the groups regarding the total operative time, number of resected lymph nodes, or incidence of postoperative complications.
SRAMIE is a feasible approach offering advantages over VAE in recovery and postoperative pain. The comparable perioperative outcomes suggest that SRAMIE may be a viable alternative to conventional MIE, warranting further large-scale studies.
机器人辅助微创食管切除术(RAMIE)已在全球范围内得到广泛应用。最近的随机对照试验表明,与传统微创食管切除术(MIE)相比,RAMIE可缩短手术时间并增加清扫淋巴结的数量。本研究对经肋下途径使用单孔(SP)机器人系统的单孔机器人辅助微创食管切除术(SRAMIE)进行了初步分析。主要目的是比较SRAMIE与使用Xi机器人系统的多孔RAMIE(MRAMIE)及电视辅助胸腔镜食管切除术(VAE)的围手术期结果。
在这项回顾性研究中,分析了2017年2月至2024年12月在单一中心接受MIE的患者。患者分为SRAMIE组(n = 17)、MRAMIE组(n = 13)和VAE组(n = 23)。主要结局是术后并发症的发生率。次要结局包括胸管留置时间、术后住院时间、术后疼痛程度和30天死亡率。
SRAMIE组未出现转为开胸手术或VAE的情况。与VAE相比,SRAMIE的胸管留置时间显著缩短(P = 0.038),术后住院时间缩短(P = 0.036),术后疼痛峰值更低(P = 0.003)。各组在总手术时间、切除淋巴结数量或术后并发症发生率方面未观察到显著差异。
SRAMIE是一种可行的方法,在恢复和术后疼痛方面优于VAE。可比的围手术期结果表明,SRAMIE可能是传统MIE的可行替代方案,值得进一步开展大规模研究。